Distinct TLR-mediated cytokine production and immunoglobulin secretion in human newborn naïve B cells

Innate Immunity

Volumn 22, Issue 6, 2016, Pages 433-443

  Pettengill, Matthew A ^a   Van Haren, Simon D ^a,d   Li, Ning ^c   Dowling, David J ^a,b   Bergelson, Ilana ^a   Jans, Jop ^a,b   Ferwerda, Gerben ^a   Levy, Ofer ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B lymphocyte; class switch recombination; cytokine; neonatal; TLR

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 21; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; CYTOKINE; INTERLEUKIN DERIVATIVE; TLR9 PROTEIN, HUMAN;

ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE REARRANGEMENT; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; INNATE IMMUNITY; NEWBORN; NORMAL HUMAN; ANIMAL; ANTIBODY PRODUCTION; B LYMPHOCYTE SUBPOPULATION; CELL CULTURE; CELL PROLIFERATION; ENZYME LINKED IMMUNOSPOT ASSAY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ADULT; ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD40; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSPOT ASSAY; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOLOGIC MEMORY; INFANT, NEWBORN; INTERLEUKINS; LYMPHOCYTE ACTIVATION; TOLL-LIKE RECEPTOR 9;

EID: 84979265957     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425916651985     Document Type: Article

References (51)

1. Lund FE,. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 2008; 20: 332-338.
2. Bernasconi NL, Onai N, Lanzavecchia A,. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003; 101: 4500-4504.
3. Kawai T, Akira S,. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-384.
4. Pasare C, Medzhitov R,. Control of B-cell responses by Toll-like receptors. Nature 2005; 438: 364-368.
5. He B, Qiao X, Cerutti A,. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 2004; 173: 4479-4491.
6. Siegrist CA, Aspinall R,. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009; 9: 185-194.
7. Dowling DJ, Levy O,. Ontogeny of early life immunity. Trends Immunol 2014; 35: 299-310.
8. Levy O,. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7: 379-390.
9. Belderbos ME, Levy O, Stalpers F, et al. Neonatal plasma polarizes TLR4-mediated cytokine responses towards low IL-12p70 and high IL-10 production via distinct factors. PLoS One 2012; 7: e33419-e33419.
10. Levy O, Coughlin M, Cronstein BN, et al. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J Immunol 2006; 177: 1956-1966.
11. Levy O, Suter EE, Miller RL, Wessels MR,. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood 2006; 108: 1284-1290.
12. Walker WE, Goldstein DR,. Neonatal B cells suppress innate toll-like receptor immune responses and modulate alloimmunity. J Immunol 2007; 179: 1700-1710.
13. Sun CM, Deriaud E, Leclerc C, Lo-Man R,. Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 2005; 22: 467-477.
14. Capolunghi F, Cascioli S, Giorda E, et al. CpG drives human transitional B cells to terminal differentiation and production of natural Abs. J Immunol 2008; 180: 800-808.
15. Tasker L, Marshall-Clarke S,. Functional responses of human neonatal B lymphocytes to antigen receptor cross-linking and CpG DNA. Clin Exp Immunol 2003; 134: 409-419.
16. Morbach H, Eichhorn EM, Liese JG, Girschick HJ,. Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol 2010; 162: 271-279.
17. Wu YC, Kipling D, Dunn-Walters DK,. The relationship between CD27 negative and positive B cell populations in human peripheral blood. Front Immunol 2011; 2: 81-81.
18. Huggins J, Pellegrin T, Felgar RE, et al. CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood 2007; 109: 1611-1619.
19. Bastian JF, Ruedi JM, MacPherson GA, et al. Lymphocyte ecto-5'-nucleotidase activity in infancy: increasing activity in peripheral blood B cells precedes their ability to synthesize IgG in vitro. J Immunol 1984; 132: 1767-1772.
20. Jain S, Chodisetti SB, Agrewala JN,. CD40 signaling synergizes with TLR-2 in the BCR independent activation of resting B cells. PLoS One 2011; 6: e20651-e20651.
21. Ozcan E, Rauter I, Garibyan L, et al. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation. J Allergy Clin Immunol 2011; 128: 601-609, e1-4.
22. Pone EJ, Lou Z, Lam T, et al. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: Modulation by BCR and CD40, and relevance to T-independent Ab responses. Autoimmunity 2015; 48: 1-12.
23. Ettinger R, Sims GP, Fairhurst AM, et al. IL-21 induces differentiation of human naive and memory B cells into Ab-secreting plasma cells. J Immunol 2005; 175: 7867-7879.
24. Spolski R, Leonard WJ,. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 2008; 26: 57-79.
25. Bekeredjian-Ding I, Jego G,. Toll-like receptors-sentries in the B-cell response. Immunology 2009; 128: 311-323.
26. Hornung V, Rothenfusser S, Britsch S, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168: 4531-4537.
27. Dasari P, Zola H, Nicholson IC,. Expression of Toll-like receptors by neonatal leukocytes. Pediatr Allergy Immunol 2011; 22: 221-228.
28. Regan T, Nally K, Carmody R, et al. Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophages. J Immunol 2013; 191: 6084-6092.
29. Pettengill MA, Levy O,. Circulating human neonatal naive B cells are deficient in CD73 impairing purine salvage. Front Immunol 2016; 7: 121-121.
30. Lo-Man R,. Regulatory B cells control dendritic cell functions. Immunotherapy 2011; 3: 19-20.
31. Krzysiek R, Lefevre EA, Zou W, et al. Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells. J Immunol 1999; 162: 4455-4463.
32. Endres R, Alimzhanov MB, Plitz T, et al. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med 1999; 189: 159-168.
33. Menard LC, Minns LA, Darche S, et al. B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanism. J Immunol 2007; 179: 4857-4866.
34. Gagro A, Servis D, Cepika AM, et al. Type I cytokine profiles of human naive and memory B lymphocytes: a potential for memory cells to impact polarization. Immunology 2006; 118: 66-77.
35. Schultze JL, Michalak S, Lowne J, et al. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: role of B cells in the maintenance of T cell responses. J Exp Med 1999; 189: 1-12.
36. Brazolot Millan CL, Weeratna R, Krieg AM, et al. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci U S A 1998; 95: 15553-15558.
37. Landers CD, Bondada S,. CpG oligodeoxynucleotides stimulate cord blood mononuclear cells to produce immunoglobulins. Clin Immunol 2005; 116: 236-245.
38. Tsuji T, Nibu R, Iwai K, et al. Efficient induction of immunoglobulin production in neonatal naive B cells by memory CD4+ T cell subset expressing homing receptor L-selectin. J Immunol 1994; 152: 4417-4424.
39. Elliott SR, Roberton DM, Zola H, Macardle PJ,. Expression of the costimulator molecules, CD40 and CD154, on lymphocytes from neonates and young children. Hum Immunol 2000; 61: 378-388.
40. Durandy A, De Saint Basile G, Lisowska-Grospierre B, et al. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J Immunol 1995; 154: 1560-1568.
41. Brugnoni D, Airo P, Graf D, et al. Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn. Eur J Immunol 1994; 24: 1919-1924.
42. Landers CD, Bondada S,. CpG oligodeoxynucleotides stimulate cord blood mononuclear cells to produce immunoglobulins. Clin Immunol 2005; 116: 236-245.
43. Seder R, Reed SG, O'Hagan D, et al. Gaps in knowledge and prospects for research of adjuvanted vaccines. Vaccine 2015; 33(Suppl. 2): B40-B43.
44. Reed SG, Orr MT, Fox CB,. Key roles of adjuvants in modern vaccines. Nat Med 2013; 19: 1597-1608.
45. Coffman RL, Sher A, Seder RA,. Vaccine adjuvants: putting innate immunity to work. Immunity 2010; 33: 492-503.
46. Kasturi SP, Skountzou I, Albrecht RA, et al. Programming the magnitude and persistence of Ab responses with innate immunity. Nature 2011; 470: 543-547.
47. Avci FY, Li X, Tsuji M, Kasper DL,. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med 2011; 17: 1602-1609.
48. Kovarik J, Bozzotti P, Love-Homan L, et al. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming. J Immunol 1999; 162: 1611-1617.
49. Weeratna RD, Brazolot Millan CL, McCluskie MJ, et al. Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived Abs. FEMS Immunol Med Microbiol 2001; 30: 241-247.
50. Cooper CL, Angel JB, Seguin I, et al. CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years. Clin Infect Dis 2008; 46: 1310-1314.
51. Cooper CL, Davis HL, Morris ML, et al. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J Clin Immunol 2004; 24: 693-701.